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disease activity in this population of patients genetically sus-
ceptible to progressive heterotopic ossification.
Flare-ups of fibrodysplasia ossificans progressiva are most
commonly triggered by soft tissue trauma. After observing
severe flare-ups of fibrodysplasia ossificans progressiva in
two half-sisters with culture-confirmed influenza B infec-
tions, we hypothesized that influenza-like viral illnesses also
can trigger fibrodysplasia ossificans progressiva flare-ups.
To address this hypothesis, we designed a questionnaire to
assess whether patients with fibrodysplasia ossificans pro-
gressiva experienced influenza symptoms during the 2000 to
2001 influenza season, and whether these symptoms were
correlated with flare-ups of the condition. The questionnaire
was sent to patients with fibrodysplasia ossificans progres-
siva worldwide. Of the 264 patients surveyed, 123 (47%)
responded. The survey revealed that the risk of a disease
flare-up of fibrodysplasia ossificans progressiva during an
influenza-like viral illness was increased at least threefold
and possibly much more. The survey data strongly supported
the hypothesis that influenza-like viral illnesses are associ-
ated with disease flare-ups in patients who have fibrodyspla-
sia ossificans progressiva. Influenza-like viral illnesses may
be a source of previously unrecognized muscle injury leading
to heterotopic ossification and permanent loss of mobility in
these patients. These findings have important implications
for understanding and preventing environmental triggers of
Fibrodysplasia ossificans progressiva (FOP) is an ex-
tremely rare and disabling genetic disease characterized by
progressive postnatal ossification of soft connective tissue
and congenital malformation of the great toeS.5.14 Autoso-
mal dominant inheritance has been shown. However, the
most cases arise from spontaneous mutations in an as yet
unidentified gene.7.S.13
The first postnatal manifestations of FOP begin in
childhood.4.14 Classically, disease flare-ups begin as
warm, painful, fibrous masses (lesions) in skeletal
muscle.4.5.14.15 In the early stages of lesional development,
there is an intense perivascular lymphocytic infiltration
into seemingly normal skeletal muscle followed by death
of skeletal muscle and fibrovascular tissue prolifera-
tion!O.14 Fibrodysplasia ossificans progressiva lesions ma-
ture through an endochondral process and form permanent
foci of heterotopic bone that bridge and immobilize adja-
cent joints, rendering movement impossible.14.15 Cur-
l h . f~. .14rent y, t ere IS no electIve treatment or preventIon.
Disease flare-ups may be stimulated by soft tissue
trauma, intramuscular injection, dental therapy, or may
occur in the absence of an identified tissue-damaging
event.4.5.14 Anecdotal reports to the authors from patients,
families, and referring physicians have suggested a tem-
poral relationship between viral respiratory illnesses and
flare-ups of FOP. The association of Epstein-Barr virus
infections with FOP flare-ups, and the dysregulation of the
bone morphogenetic protein (BMP) pathway in Epstein-
Barr virus-infected FOP cells provide a background for
cautionary surveillance of other viral triggers in patients
with FOp.14.22 Recently, we observed severe flare-ups of
FOP leading to mobility restriction in two half-sisters with
FOP within 12 hours of the onset of symptoms of culture-
confirmed influenza B infection.14
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We hypothesized that influenza-like viral illnesses can
trigger FOP flare-ups. To test this hypothesis a question-
naire was designed to assess whether patients with FOP
experienced influenza-like viral symptoms during the
2000 to 2001 influenza season, and whether influenza-like
viral symptoms were associated with flare-ups of FOP.
MATERIALS AND METHODS
Fig 1. A lateral radiograph was obtained of the cervical spine
of a 5-year-old child, 6 months after a flare-up of FOP involving
the neck that was coincident with culture-confirmed influenza
B infection. The child had full ROM of the neck before the
influenza-induced flare-up. However, as a result of the hetero-
topic ossification (arrow) from the occiput to the spinous pro-
cess of C7, the neck became ankylosed.
The influenza viruses (subtypes A and B) infect mil-
lions of people worldwide annually?! The classic symp-
toms of influenza infection are fever, nonproductive
cough, nasal congestion, myalgias, sore throat, headache,
and malaise lasting between 1 and 2 weeks?! The gener-
alized myalgias associated with influenza and other acute
viral illnesses usually are mild and self-limiting. However,
more severe muscle syndromes, ranging from myositis to
rhabdomyolysis have been reported in patients with influ-
enza infections.!9 Myositis and rhabdomyolysis most
commonly are seen in children infected with influenza A
or B.!9 The cause of muscle injury in influenza infections
is unclear. Several possible mechanisms have been hy-
pothesized, including direct invasion of muscle tissue by
the virus,9 activation of proinflammatory transcription fac-
tors,2 and autoimmune processes.3
A detailed questionnaire was posted on the International Fibro-
dysplasia Ossificans Progressiva Association (IFOPA) website
(www.ifopa.org). The IFOPA includes 264 self-enrolled patient-
members (115 males, 149 females) from 26 countries and five
continents. Fibrodysplasia ossificans progressiva was verified in
all patients either through previous examination by one of the
authors (FSK) or through previous surveys and review of rel-
evant photographs and radiographs. The study and questionnaire
were approved by the institutional review board (IRB) of one of
our institutions. Patient confidentiality was guaranteed in public
reporting of all results in accordance with standards set by the
IRB. Informed consent was obtained from all participants. As
required by the IRB, patients were asked to sign a consent form
in which they were informed that the "the data from this ques-
tionnaire will enable us to better examine the relationship (if
any) between influenza and FOP."
Members with e-mail addresses were contacted directly and
requested to complete the electronic questionnaire. Question-
naires were sent by mail to members of the IFOPA who did not
complete the electronic version within 4 weeks of its initial
posting. Parents of affected children and caretakers of extremely
disabled adults were requested to complete the questionnaires.
The electronic version of the survey was posted on the IFOP A
web site until the conclusion of the study. The survey was de-
signed to ascertain each patient's age, history of influenza vac-
cination, history of influenza-like viral symptoms (muscle aches,
fever, chills, cough, nasal congestion, sore throat, enlarged
lymph nodes, and fatigue), other symptoms (nausea, vomiting,
and diarrhea), duration of symptoms, occurrence of similar
symptoms in household members, and change in the status of
FOP during the survey period (lesion formation, regression,
changes in shape, size, and location of existing lesions, and the
temporal association of influenza-like viral illnesses with flare-
ups of FOP).
Patient histories were used to determine influenza-like viral
illnesses and temporal relationship to changes in FOP. The sur-
vey investigated only the most recent influenza season (October
2000 through April 200 1) because patient recall would be more
reliable.18 Although the seasonal prevalence of influenza is re-
versed in the two hemispheres of Earth, we did not exclude
surveys from patients from the southern hemisphere as all non-
seasonal influenza-like illnesses were accounted for by the ques-
tionnaire.
The two patients with FOP who prompted the initiation of
this study had viral cultures that confirmed influenza B infec-
tions.14 Although viral cultures are the most sensitive method of
confirming influenza infection, such cultures were impossible to
collect for this retrospective study. To avoid presumptions, we
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refer to all persons having symptoms consistent with influenza as
having an influenza-like viral illness.20
To be classified as having an influenza-like viral illness, pa-
tients had to report having fever or chills, cough, and nasal
congestion, simultaneously for 7 to 14 days. Monto et al reported
a positive predictive value of 81 % for having laboratory-
confirmed influenza when fever, cough, and nasal congestion
were present within the first 48 hours of the onset of an influ-
enza-like viral illness!O
Odds-ratio and relative risk confidence intervals and Fisher's
exact test were used to calculate the statistical significance of the
association between flare-ups of FOP and influenza-like viral
illnesses.!
RESULTS
A questionnaire to evaluate influenza-like symptoms in
patients with FOP had 123 respondents (53 males, 70 fe-
males), representing 47% of the 264 patient-members of
the IFOPA. Ninety of the 156 members (58%) with e-mail
addresses completed the electronic questionnaire. Thirty-
three of the 108 (31 %) questionnaires sent by mail were
completed. There were no duplicate responses. The age of
the respondents ranged from 3 to 72 years (mean age, 27
years).
Of the 123 respondents, 10 (8%) met the criteria of
having an influenza-like viral illness during the study pe-
riod. AIII0 respondents described having the three requi-
site signs (fever, cough, nasal congestion) and sore throat,
enlarged lymph nodes, and severe fatigue. Nine of the 10
patients described having generalized myalgias. Eight of
the 10 patients reported that other household members
simultaneously experienced similar symptoms.
Of the 10 patients who were characterized as having
had an influenza-like viral illness, six (one male, five fe-
males; mean age, 29 years) reported experiencing a dra-
matic decline in their FOP status as a result of the viral
illness (Table 1). All six patients described symptoms con-
sistent with a flare-up of FOP (pain, severe soft tissue
swelling, and warmth) within 24 to 72 hours of the onset
of influenza-like viral symptoms. The neck was the most
commonly affected site, with all six patients describing
neck involvement. Other affected sites included the back,
trunk, groin, and legs. One patient reported regression of
her FOP lesions within 3 weeks of recovering from the
infection. However, the five other patients described le-
sions that persisted for longer than 3 months and resulted
in permanent loss of mobility. Four patients (one male,
three females; mean age, 29 years) who met the criteria for
having an influenza-like viral illness did not experience a
flare-up of FOP (Table 1). Three patients in this group
reported household members having similar flu-like symp-
toms.
Of the 113 patients (51 males, 62 females; mean age, 27
years) who did not meet the criteria for having an influ-
enza-like viral illness, 12 (11 %) described flare-ups during
the influenza season (Table 1). All 12 patients (seven
males, five females; mean age, 22 years) described some
influenza-like symptoms (most commonly fever) but ei-
ther lacked the two other mandatory symptoms (cough and
nasal congestion), or did not experience the symptoms for
the requisite 7 to 14 days. Commonly, patients having a
flare-up of FOP report having fevers during periods of
induration, which mistakenly can suggest an infectious
process or tumor.14 Four patients in this group reported
that other household members experienced similar influ-
enza-like symptoms. Only one of this group of 12 patients
described a flare-up involving the neck whereas five of the
six patients with flare-ups and influenza-like viral illnesses
experienced a flare-up in the neck. Other affected sites for
disease flare-ups in the patients who did not experience
influenza-like viral illnesses included the legs, arms, ab-
domen, and submandibular region.
When compared with the incidence of flare-ups of FOP
in the group without influenza-like symptoms (11 %;
12/113), it was evident that individuals experiencing in-
fluenza-like viral illnesses were at a substantially greater
risk (60%; 6/10) of having flare-ups of FOP (p = 0.0006
by Fisher's exact test). The observed odds ratio was 12.62
TABLE 1. Clinical Survey Data of Influenza-like Viral Illnesses and Disease
Flare-ups in Patients With FOP
No flare-up
Total
18
(8 males, 10 females)
(mean age. 24 years)
105
(45 males. 60 females)
(mean age, 28 years)
123
(53 males, 70 females)
(mean age, 27 years)
12
(7 males, 5 females)
(mean age, 22 years)
101
(44 males, 57 females)
(mean age. 28 years)
113
(51 males, 62 females)
(mean age, 27 years)
6
(1 male. 5 females)
(mean age. 28 years)
4
(1 male. 3 females)
(mean age, 29 years)
10
(2 males, 8 females)
(mean age, 29 years)
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with a 95% confidence interval of(3.11, 51.18). The rela-
tive risk was 5.65 with a 95% confidence interval of (2.70,
11.80). Therefore, it appears that the risk of an FOP flare-
up is elevated during an influenza-like illness by at least a
factor of 3 and possibly much more.
Twenty-eight (23%) of the study respondents reported
receiving an influenza vaccination (which usually is ad-
ministered intramuscularly) for the 2000 to 2001 influenza
season. Of the 28 patients who received the influenza vac-
cine (mean age, 35 years), only one experienced symptoms
that met our criteria for an influenza-like infection. Two
patients reported having the influenza vaccination admin-
istered subcutaneously. None of the 28 patients who re-
ceived the vaccination during the study period reported an
adverse reaction.
DISCUSSION
After observing severe flare-ups of FOP in two half-sisters
with culture confirmed influenza B infections, we hypoth-
esized that influenza-like viral illnesses can trigger FOP
flare-ups. To test this hypothesis, we designed a question-
naire to assess whether patients with FOP experienced
influenza-like viral symptoms during the 2000 to 2001
influenza season, and whether influenza-like viral symp-
toms were associated with flare-ups of FOP. Although this
study was not designed to establish cause and effect by
Koch's postulates, it determined a plausible relationship
between influenza-like viral illnesses and flare-ups of
FOP.
The design of this study may have introduced several
methodologic biases. First, the consent form may have
inadvertently biased recall and responses as the hypothesis
was known to the study participants. Nevertheless, the
patients were told that there may be no relationship be-
tween influenza-like illnesses and FOP. Second, the study
relied on the memories of patients and their families to
determine influenza-like viral illnesses and flare-ups of
FOP. To minimize recall bias, the study was limited to the
most recent (2000-2001) influenza season before com-
mencement of data collection.Is Although there is greater
uncertainty from patient histories than from clinician-
generated medical records, patients with FOP are reliable
judges of disease flare-ups.4.IS Third, although there was a
large response to the survey, more than Vz of the targeted
patients did not complete the survey. We were unable to
obtain useful information with respect to influenza-like
viral illnesses and flare-ups in these patients. Fourth, the
survey criteria used to determine influenza infection are
not as sensitive as viral cultures, the gold standard for
confirming influenza infection. The 81 % positi ve predic-
ti ve value that Monto et afo described for culture-
confirmed influenza infection in patients experiencing fe-
ver, cough, and nasal congestion examined only the first
48 hours of influenza-like symptoms!O To date, no pub-
lished study has examined the most sensitive symptoms
for establishing influenza infection for the duration of in-
fluenza-like viral illnesses. Despite these limitations, the
data strongly suggest that influenza-like viral illnesses are
associated with disease flare-ups in patients who have
FOP.
The mechanism by which influenza-like viral illnesses
may elicit flare-ups of FOP is not clear; however, several
theories have been considered. Considering the sensitivity
of FOP to trauma, it is reasonable to suggest that a flare-up
might result from microtrauma caused by virus infecting
muscle fibers,9 or that the influenza virus might elicit an
autoimmune response in skeletal muscle.3 Additionally,
many viral illnesses activate proinflammatory transcrip-
tion factors in vivo, which may incite flare-ups of FOP.2
Finally, influenza virus might affect the expression of
BMPs or their antagonists in lymphocytes or muscle tissue
of susceptible individuals.I2.I4.22 Additional investigation
is needed to establish the specific mechanisms by which
influenza-like viruses induce flare-ups of FOP.
Patients who have FOP have severe restrictive disease
of the chest wall at an early age and have a high risk
throughout life for having life-threatening complications
of respiratory infections.I4.I6 The results of this study sug-
gest that patients with FOP may have an additional sub-
stantial risk of having temporally-associated disease flare-
ups from influenza-like viral illnesses. Such flare-ups af-
fecting the chest wall would additionally imperil the
already precarious respiratory status in a patient with FOP.
Patients with FOP should promptly seek medical attention
of influenza-like syndromes.
Although prospective studies are necessary to deter-
mine the exact identity, scope, and magnitude of influ-
enza-like viral illnesses that trigger fibrodysplasia ossifi-
cans progressiva flare-ups, it is tempting to suggest that
patients with FOP consider receiving influenza immuni-
zations annually.6 Additionally, unaffected household
members of patients with FOP might consider annual im-
munizations. Prophylaxis with approved orally-inhaled an-
tiviral medications after household contact may prevent
clinical illness in unvaccinated individuals.6
It is recommended that patients who have FOP avoid
intramuscular immunizations. I? Influenza immunizations
can be administered subcutaneously in patients with FOP
to avoid the possibility of having heterotopic ossification
develop at the inoculation site. I I Other subcutaneous vac-
cinations (measles-mumps-rubella) have not been reported
to elicit flare-ups in patients who have FOP.I? An intra-
nasal influenza vaccine now is available and is approved
for administration, where not otherwise contraindicated, in
individuals from 5 to 49 years of age.6 This would circum-
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vent the need for either an intramuscular or subcutaneous
injection, and might be an attractive option in this patient
population. Future studies also might be designed to de-
termine if the intranasal influenza vaccine and approved
treatments such as oseltarnivir or zanamivir which are
proven to be effective in reducing the severity and duration
of influenza symptoms also might be effective in prevent-
ing flare-ups.6
Our study suggests that influenza-like viral illnesses are
associated with disease flare-ups leading to mobility re-
striction in patients who have FOP. These findings have
important implications for understanding and preventing
environmental triggers of disease activity in this popula-
tion of patients who are genetically susceptible to progres-
sive and disabling heterotopic ossification.
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